Walleye Trading LLC Cerus Corp Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $113,757 - $232,822	75,838 New	75,838 $122,000
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $14,254 - $20,871	-2,915 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.89 - $7.78 $20,084 - $22,678	2,915 New	2,915 $21,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $11,578 - $16,174	-2,231 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.56 - $5.74 $463,611 - $747,508	-130,228 Reduced 98.32%	2,231 $12,000
Q2 2017 Aug 14, 2017	BUY	N/A	132,459	132,459 $332,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $322M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.